Himsagar Laboratories Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 19-12-2024
- Paid Up Capital ₹ 5.72 M
as on 19-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.12 Cr
as on 19-12-2024
- Revenue 59.43%
(FY 2022)
- Profit 52.30%
(FY 2022)
- Ebitda 1.02%
(FY 2022)
- Net Worth 8.94%
(FY 2022)
- Total Assets 32.31%
(FY 2022)
About Himsagar Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.72 M.
The company currently has active open charges totaling ₹6.12 Cr.
Keshav Saini, Sunita Rani, and Swaraj Saini serve as directors at the Company.
- CIN/LLPIN
U24232DL2005PLC132560
- Company No.
132560
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Himsagar Laboratories Limited offer?
Himsagar Laboratories Limited offers a wide range of products and services, including Pharmaceutical Medicine, Lycopene Syrup.
Who are the key members and board of directors at Himsagar Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Keshav Saini  | Director | 27-Jan-2006 | Current |
| Sunita Rani | Director | 27-Jan-2006 | Current |
| Swaraj Saini | Director | 25-Mar-2010 | Current |
Financial Performance of Himsagar Laboratories.
Himsagar Laboratories Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.43% increase. The company also saw a substantial improvement in profitability, with a 52.3% increase in profit. The company's net worth moved up by a moderate rise of 8.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Himsagar Laboratories?
In 2022, Himsagar Laboratories had a promoter holding of 81.00% and a public holding of 19.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Apr 2022 | ₹1.25 M | Open |
Others Creation Date: 09 Jun 2020 | ₹2.40 M | Open |
Punjab National Bank Creation Date: 22 Jun 2007 | ₹4.20 M | Open |
How Many Employees Work at Himsagar Laboratories?
Himsagar Laboratories has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Himsagar Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Himsagar Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
